Why Did My Depression Come Back?
understanding relapse and what to do differently this time

You thought you were past it. You did the work. You took the medication, went to therapy, rebuilt your routines, and slowly started feeling like yourself again. Months went by, maybe years. And then, one morning, you woke up and recognized the feeling. The heaviness. The fog. The emptiness creeping back in like a tide you thought had gone out for good.

If your depression has returned, the first thing you need to know is this: it's not your fault, and you're not back at square one. Depression relapse is one of the most well documented features of the illness. Understanding why it happens and what you can do differently this time is the most powerful thing you can do right now.

Relapse Is the Rule, Not the Exception

This is the statistic that changes how most people think about depression: almost 80% of patients with major depressive disorder experience at least one further episode in their lifetime, and the probability of recurrence increases with each episode. After a first episode, approximately half of patients will experience a relapse or recurrence. Those who relapse are more likely to relapse again compared with those who don't.

A large population cohort study tracked over 700 individuals in remission from major depression and found that the cumulative recurrence rate was 4.3% at 5 years, 13.4% at 10 years, 27.1% at 20 years, and 55.1% at 43 years. The risk never fully disappears.

These numbers aren't meant to be discouraging. They're meant to reframe depression as what it actually is: a chronic, episodic illness, more like asthma or diabetes than a broken bone. You wouldn't feel ashamed if your asthma flared up. Depression deserves the same framework.

Why It Comes Back: The Biggest Risk Factors

A landmark four-phase systematic review and meta-synthesis identified the factors most strongly associated with depression relapse and recurrence. Three stand out above all others:

1. Residual symptoms. This is the single most actionable risk factor. If your last episode ended with "I feel mostly better" rather than "I feel fully well," those lingering symptoms (mild sadness, ongoing fatigue, persistent sleep problems, low-grade difficulty concentrating) significantly increase your risk of relapse. Research has found strong evidence that residual depressive symptoms are prognostic for relapse and recurrence. Even subthreshold symptoms that persist after acute treatment predict future episodes.

This matters because many people (and many treatment plans) stop at "better" instead of pushing for full remission. Feeling 70% better is not the same as being well, and the remaining 30% isn't just discomfort. It's a vulnerability.

2. Number of previous episodes. Each depressive episode increases the likelihood of another one. The mechanism behind this is sometimes called "kindling," the idea that each episode sensitizes the brain, making it progressively easier for depression to be triggered by smaller and smaller stressors, or even by no identifiable stressor at all.

3. Childhood maltreatment. Early adverse experiences emerged as one of the three strongest prognostic indicators for relapse. The mechanism likely involves long-term changes to the stress response system (the HPA axis) and to the neural circuits that process emotions and regulate mood. If you experienced significant adversity in childhood, you're not destined to relapse, but you may benefit from treatments specifically designed to address the downstream consequences of early trauma.

Other factors associated with increased relapse risk include comorbid anxiety, neuroticism (a personality trait characterized by emotional reactivity), younger age of first onset, rumination (the tendency to repetitively dwell on negative thoughts), and major life stressors occurring after treatment.

What Happens in Your Brain When Depression Returns

When antidepressant medication is discontinued, the brain doesn't simply revert to "normal." Research has shown that stopping antidepressants increases amygdala reactivity to negative emotional information, and this increase is directly associated with relapse risk. The amygdala is the brain's threat-detection center, and antidepressants appear to dampen its overreactivity. When that dampening is removed, negative emotional stimuli hit harder, which can retrigger the depressive cascade.

This finding is significant because it suggests that antidepressants aren't just treating symptoms. They may be actively protecting the brain from the emotional triggers that initiate relapse.

The ANTLER Trial: What Happens When You Stop Medication

One of the most important studies on this question is the ANTLER trial, a randomized controlled trial conducted in UK primary care. Patients who had been taking antidepressants long-term and felt well enough to consider stopping were randomly assigned to either continue their medication or gradually taper and discontinue it.

The results were stark. Over 52 weeks, patients who discontinued their antidepressant had roughly double the risk of depression relapse compared to those who continued (hazard ratio 2.06). The survival curves separated early and continued to diverge throughout the entire year, showing that the increased relapse risk was not a short-term withdrawal effect but a sustained vulnerability.

What to Do Differently This Time

Push for full remission, not just improvement. Work with your provider to target complete symptom resolution, not just feeling "okay." Treating residual symptoms, whether through medication optimization, CBT, or a combination, is one of the most evidence-based strategies for preventing the next episode.

Don't stop medication prematurely. The meta-analytic evidence is clear: continuing antidepressants after remission significantly reduces relapse risk. Across 40 studies involving nearly 9,000 patients, the relapse rate was 20.9% with continued medication versus 39.7% with placebo, a roughly 50% relative risk reduction. Current guidelines recommend maintaining antidepressant therapy for at least 12 months after remission, and longer for patients with multiple prior episodes or other risk factors.

If you do want to stop medication, do it with a plan. Tapering should be gradual, guided by your provider, and ideally accompanied by a psychological intervention. An individual participant data meta-analysis found that sequential psychological interventions (such as preventive cognitive therapy or mindfulness-based cognitive therapy) delivered during or after antidepressant tapering can be an effective alternative to long-term medication, particularly for patients at high risk of relapse.

Add relapse prevention therapy. Mindfulness-based cognitive therapy (MBCT) was specifically developed to prevent depression relapse. It targets rumination, the repetitive negative thinking pattern that both predicts and perpetuates depressive episodes. MBCT has been shown to be equally effective as maintenance antidepressants for preventing relapse, and more effective than usual care alone, particularly for patients with three or more previous episodes.

Address your specific risk factors. If comorbid anxiety is present, treat it. If rumination is a pattern, target it specifically. If childhood adversity plays a role, consider trauma-informed therapy. If life stressors are accumulating, build a plan for managing them before they trigger a relapse. The evidence shows that these factors aren't just risk markers. Several of them are prescriptive, meaning that targeting them directly can change the outcome.

Build a monitoring system. Depression relapse often begins with subtle changes, a few nights of poor sleep, a gradual withdrawal from activities, the return of that familiar inner critic, before it becomes a full episode. Periodic self-screening (the PHQ-9 takes two minutes), regular check-ins with your provider, and honest conversations with people who know you well can help catch a relapse early, when it's most treatable.

The Bottom Line

If your depression has come back, you haven't failed. You have a recurrent medical condition, and it has recurred. The difference between this time and last time is that you now know more about what you're dealing with. You know that residual symptoms matter, that medication discontinuation carries real risk, that specific therapies can prevent relapse, and that each episode teaches you something about your own vulnerability.

Recovery isn't a straight line. But each time you return to treatment armed with better information and a more targeted plan, the odds shift in your favor.